ArticleNPJ precision oncology2024

ACSL3 is an unfavorable prognostic marker in cholangiocarcinoma patients and confers ferroptosis resistance in cholangiocarcinoma cells.

Apiwit Sae-Fung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.